| Forever Smiles | |
|
6363 Kentucky Route 1428 Allen KY 41601 | |
| (606) 949-6971 | |
| (606) 949-6986 |
| Full Name | Forever Smiles |
|---|---|
| Speciality | Dentist - General Practice |
| Location | 6363 Kentucky Route 1428, Allen, Kentucky |
| Authorized Official Name and Position | Jeffery Dye (PRESIDENT) |
| Authorized Official Contact | 6069496971 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Forever Smiles Po Box 308 6363 Kentucky Route 1428 Allen KY 41601 Ph: (606) 949-6971 | Forever Smiles 6363 Kentucky Route 1428 Allen KY 41601 Ph: (606) 949-6971 |
| NPI Number | 1083988596 |
|---|---|
| Provider Enumeration Date | 03/01/2012 |
| Last Update Date | 07/18/2015 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083988596 | NPI | - | NPPES |
| 60069770 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 6977 (Kentucky) | Primary |
| 1223G0001X | Dentist - General Practice | 7084 (Kentucky) | Secondary |
News Archive
Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin's lymphoma that accounts for approximately 40 percent of lymphomas among adults. If left untreated, it is fatal. The existing treatments have a cure rate that is slightly over 50 percent but destroy healthy cells along with the cancer cells.
An international consortium of scientists, including major contributions from the Montreal Heart Institute, demonstrates that the "one-size fits all" strategy of uniformly doubling the dose of an antiplatelet drug, clopidogrel, for patients with high on-treatment platelet reactivity does not reduce the incidence on death, heart attacks and stent thrombosis after percutaneous coronary intervention.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, in combination with erlotinib, a small molecule directed at the epidermal growth factor receptor (EGFR), in three groups of patients with metastatic non-small cell lung cancer.
New research provides clues about the causes of lupus symptoms and suggests specific new targeted treatment strategies, according to Nilamadham Mishra, M.D., from Wake Forest University Baptist Medical Center, in presentations this week at the American College of Rheumatology in Boston.
Full Motion Beverage, Inc. a new age beverage company has signed a letter of intent (LOI) with WM Holdings, LLC, makers of GX Supplements.
› Verified 1 days ago
Economy Dentures Plus Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 6363 Ky Route 1428, Allen, KY 41601 Phone: 606-874-0678 |